Previous studies have reported that apelin (a peptide hormone linked with obesity and diabetes) and its receptor inhibit vascular injury in diabetes, including the endocrine response to stress, lipid metabolism, homeostasis and angiogenesis [28,29]. Here, APLN is linked to Obesity.